Cashing in on Omicron

As always, it doesn’t matter whether the Omicron panic is warranted or not. All you need to care about is how the change in outlook could affect you and your money. Our science advisor, Ray Blanco, walks us through it in this week’s Session. You’ll learn how Omicron will affect the major vaccine makers’ bottom lines… as well as details on biotech breakthroughs that could become big news as COVID finally fades into the background. Here’s this week’s warm-up to today’s conversation.